Innovate UK is to invest up to £10m in two-phase SBRI competition

Innovate UK is to invest up to £10m in a two-phase competition to promote the development of new diagnostic products and services for use in stratified medicine.

An SBRI competition aims to accelerate and/or increase the development and adoption of innovative diagnostic tools in order to offer better targeted treatment to patients within the UK healthcare system. It also aims to demonstrate the benefits of companies working within the UK ‘enabling infrastructure’, which is made up of specialist organisations that can help companies understand healthcare needs and design, evaluate and deliver their products and services into the NHS.

Up to £2m is available for phase 1 of the competition and up to a further £8m may be available in a second phase to further develop successful phase 1 projects. The competition is open to all organisations that can demonstrate a route to market for their solution. Successful organisations will attract a 100% funded development contract of up to £150,000 over nine months in phase 1, with the potential to apply for up to £2m over a further three years in phase 2.

For more information on the types of projects that will supported and key dates visit https://interact.innovateuk.org/competition-display-page/-/asset_publisher/RqEt2AKmEBhi/content/stratified-medicine-connecting-the-uk-infrastructure or read the Stratified Medicine Connecting the UK infrastructure briefing document.

You may also be Interested in

Driving rural and coastal health innovation: Our Impact Report 2025-26

Driving rural and coastal health innovation: Our Impact Report 2025-26

Read more
Brian’s Story – myCOPD

Brian’s Story – myCOPD

Read more
Accelerating ICB Innovation: New report outlines insights to strengthen adoption readiness

Accelerating ICB Innovation: New report outlines insights to strengthen adoption readiness

Read more
PReCePT linked to national levelling up of maternity care

PReCePT linked to national levelling up of maternity care

Read more
Newsletter

Stay up to date

Sign up to hear more from us

Back to top